Mandate

Vinge advises Transtema in connection with listing on Nasdaq Stockholm

Vinge has advised Transtema in connection with its application for admission to trading on Nasdaq Stockholm’s main list.

The Nasdaq Companies Committee approved the application on 17 September 2021, and Transtema published the prospectus on the same day. The first day of trading is planned to take place on 29 September.

Vinge’s team primarily consisted of Anders StridEdin Agic (Project Manager), Jacob BenzovLina André (Banking and Finance), Anna Backman (Employment Law), Alexander Lindeberg (IP/IT) and Anna Högsten (IP/IT)

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025